Decision support for heart failure diagnosis and monitoring
Part of Heart & circulation clinical trials.
This study is testing a decision-support system to help doctors diagnose heart failure and track how it progresses. It may be an option if you are 45 or older and have signs of heart failure or a recent diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- You either have symptoms or signs of heart failure (but no diagnosis) with risk factors like high blood pressure, diabetes, or heart disease, OR you have been diagnosed with heart failure in the last 24 months or were hospitalized for it.
- You are willing to visit a research facility and can give your written consent to participate.
- You do not have severe symptoms, a major illness like cancer or severe lung disease, or a recent heart attack (within 60 days).
- You do not have a pacemaker or defibrillator implanted in the last 3 months, severe kidney disease, or a life expectancy less than 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests whether a wearable home monitoring system (myCordella™) can help people with moderate heart failure (NYHA class II or III) by tracking heart pressure and supporting follow-up care. It may help detect changes earlier so clinicians can adjust treatment sooner.
This study tests whether a heart-related device called CCM can improve symptoms and daily function in people with heart failure and a moderately reduced pumping strength. It may help if you’ve had recent heart-failure-related hospital care or urgent treatment and your heart and overall health fit the study limits.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.